Hata K, Kikuchi K, Tada K, Tsuiki S
Biochemistry Laboratory, Tohoku University, Sendai.
Tohoku J Exp Med. 1988 Jun;155(2):173-81. doi: 10.1620/tjem.155.173.
A membrane filter procedure developed by Igarashi et al. (1984) for the measurement of glucose 6-phosphate uptake by the microsomes has been demonstrated to be a good method for assaying glucose-6-phosphate translocase, an obligatory component of the microsomal glucose-6-phosphatase system. When glucose-6-phosphate translocase was assayed in developing and diabetic rat livers independently of hexose-6-phosphate phosphohydrolase, another obligatory component of the glucose-6-phosphatase system, the two activities were found to undergo alterations, whose profiles, however, were quite distinct from each other. The profile of the microsomal glucose-6-phosphatase activity resembles the profile of the phosphohydrolase activity rather than that of the translocase activity, suggesting that the phosphohydrolase may be rate-limiting at least under these conditions. AH-109A, a strain of transplantable rat ascites hepatoma, was found to lack both glucose-6-phosphate translocase and hexose-6-phosphate phosphohydrolase activities.
Igarashi等人(1984年)开发的一种用于测量微粒体摄取6-磷酸葡萄糖的膜过滤方法,已被证明是一种检测6-磷酸葡萄糖转运酶的好方法,6-磷酸葡萄糖转运酶是微粒体6-磷酸葡萄糖酶系统的一个必需成分。当在发育中的和糖尿病大鼠肝脏中独立于6-磷酸己糖磷酸水解酶(6-磷酸葡萄糖酶系统的另一个必需成分)检测6-磷酸葡萄糖转运酶时,发现这两种活性会发生变化,然而,它们的变化模式彼此截然不同。微粒体6-磷酸葡萄糖酶活性的变化模式更类似于磷酸水解酶活性的变化模式,而不是转运酶活性的变化模式,这表明磷酸水解酶可能至少在这些条件下是限速的。发现可移植大鼠腹水肝癌细胞系AH-109A既缺乏6-磷酸葡萄糖转运酶活性,也缺乏6-磷酸己糖磷酸水解酶活性。